 | Up a level |
Mukhopadhyay, Chandrani; Yang, Chenyi; Xu, Limei; Liu, Deli; Wang, Yu; Huang, Dennis; Deonarine, Lesa Dayal; Cyrta, Joanna; Davicioni, Elai; Sboner, Andrea; Robinson, Brian D; Chinnaiyan, Arul M; Rubin, Mark A; Barbieri, Christopher E; Zhou, Pengbo (2021). G3BP1 inhibits Cul3SPOP to amplify AR signaling and promote prostate cancer. Nature Communications, 12(1), p. 6662. Springer Nature 10.1038/s41467-021-27024-x
Krentel, Friedemann; Singer, Franziska; Rosano-Gonzalez, María Lourdes; Gibb, Ewan A; Liu, Yang; Davicioni, Elai; Keller, Nicola; Stekhoven, Daniel J; Kruithof-de Julio, Marianna; Seiler-Blarer, Roland (2021). A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancer. Scientific Reports, 11(1), p. 5849. Nature Publishing Group 10.1038/s41598-021-85151-3
Grivas, Petros; Bismar, Tarek A; Alva, Aijai S; Huang, Huei-Chung; Liu, Yang; Seiler, Roland; Alimohamed, Nimira; Cheng, Liang; Hyndman, M Eric; Dabbas, Bashar; Black, Peter C; Davicioni, Elai; Wright, Jonathan L; Ornstein, Moshe C; Mian, Omar Y; Kaimakliotis, Hristos Z; Gibb, Ewan A; Lotan, Yair (2020). Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy. Urologic oncology, 38(4), pp. 262-268. Elsevier 10.1016/j.urolonc.2019.11.004
Genitsch, Vera; Kollár, Attila; Vandekerkhove, Gillian; Blarer, Jennifer; Furrer, Marc; Annala, Matti; Herberts, Cameron; Pycha, Armin; de Jong, Joep J; Liu, Yang; Krentel, Friedemann; Davicioni, Elai; Wyatt, Alexander W; Gibb, Ewan A; Kruithof-de Julio, Marianna; Seiler, Roland (2019). Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer. Urologic oncology - seminars and original investigations, 37(11), pp. 826-836. Elsevier 10.1016/j.urolonc.2019.09.025
de Jong, Joep J; Liu, Yang; Robertson, A Gordon; Seiler, Roland; Groeneveld, Clarice S; van der Heijden, Michiel S; Wright, Jonathan L; Douglas, James; Dall'Era, Marc; Crabb, Simon J; van Rhijn, Bas W G; van Kessel, Kim E M; Davicioni, Elai; Castro, Mauro A A; Lotan, Yair; Zwarthoff, Ellen C; Black, Peter C; Boormans, Joost L; Gibb, Ewan A (2019). Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis. Genome medicine, 11(1), p. 60. BioMed Central 10.1186/s13073-019-0669-z
Batista da Costa, José; Gibb, Ewan A; Bivalacqua, Trinity J; Liu, Yang; Oo, Htoo Zarni; Miyamoto, David T; Alshalalfa, Mohammed; Davicioni, Elai; Wright, Jonathan; Dall'Era, Marc A; Douglas, James; Boormans, Joost L; Van der Heijden, Michiel S; Wu, Chin-Lee; van Rhijn, Bas W G; Gupta, Shilpa; Grivas, Petros; Mouw, Kent W; Murugan, Paari; Fazli, Ladan; ... (2019). Molecular Characterization of Neuroendocrine-like Bladder Cancer. Clinical cancer research, 25(13), pp. 3908-3920. American Association for Cancer Research 10.1158/1078-0432.CCR-18-3558
Efstathiou, Jason A; Mouw, Kent W; Gibb, Ewan A; Liu, Yang; Wu, Chin-Lee; Drumm, Michael R; da Costa, Jose Batista; du Plessis, Marguerite; Wang, Natalie Q; Davicioni, Elai; Feng, Felix Y; Seiler, Roland; Black, Peter C; Shipley, William U; Miyamoto, David T (2019). Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer. European urology, 76(1), pp. 59-68. Elsevier 10.1016/j.eururo.2019.01.011
Genitsch, Vera; Kollár, Attila; Vandekerkhove, Gillian; Blarer, Jennifer; Furrer, Marc; Annala, Matti; Herberts, Cameron; Pycha, Armin; de Jong, Joep J.; Liu, Yang; Krentel, Friedemann; Davicioni, Elai; Gibb, Ewan A.; Kruithof-de Julio, Marianna; Wyatt, Alexander W.; Seiler, Roland (2019). Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer. Urologic oncology - seminars and original investigations, 37(9), 573.e19-573.e29. Elsevier 10.1016/j.urolonc.2019.06.021
Zhao, Shuang G; Chang, S Laura; Erho, Nicholas; Yu, Menggang; Lehrer, Jonathan; Alshalalfa, Mohammed; Speers, Corey; Cooperberg, Matthew R; Kim, Won; Ryan, Charles J; Den, Robert B; Freedland, Stephen J; Posadas, Edwin; Sandler, Howard; Klein, Eric A; Black, Peter; Seiler, Roland; Tomlins, Scott A; Chinnaiyan, Arul M; Jenkins, Robert B; ... (2017). Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy. JAMA oncology, 3(12), pp. 1663-1672. American Medical Association 10.1001/jamaoncol.2017.0751
Seiler, Roland; Ashab, Hussam Al Deen; Erho, Nicholas; van Rhijn, Bas W G; Winters, Brian; Douglas, James; Van Kessel, Kim E; Fransen van de Putte, Elisabeth E; Sommerlad, Matthew; Wang, Natalie Q; Choeurng, Voleak; Gibb, Ewan A; Palmer-Aronsten, Beatrix; Lam, Lucia L; Buerki, Christine; Davicioni, Elai; Sjödahl, Gottfrid; Kardos, Jordan; Hoadley, Katherine A; Lerner, Seth P; ... (2017). Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy. European urology, 72(4), pp. 544-554. Elsevier 10.1016/j.eururo.2017.03.030
Alshalalfa, Mohammed; Verhaegh, Gerald W; Gibb, Ewan A; Santiago-Jiménez, Maria; Erho, Nicholas; Jordan, Jennifer; Yousefi, Kasra; Lam, Lucia L C; Kolisnik, Tyler; Chelissery, Jijumon; Seiler, Roland; Ross, Ashley E; Karnes, R Jeffrey; Schaeffer, Edward M; Lotan, Tamara T; Den, Robert B; Freedland, Stephen J; Davicioni, Elai; Klein, Eric A and Schalken, Jack A (2017). Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients. OncoTarget, 8(31), pp. 50804-50813. Impact Journals LLC 10.18632/oncotarget.15133
Seiler, Roland; Oo, Htoo Zarni; Tortora, Davide; Clausen, Thomas M; Wang, Chris K; Kumar, Gunjan; Pereira, Marina Ayres; Ørum-Madsen, Maj S; Agerbæk, Mette Ø; Gustavsson, Tobias; Nordmaj, Mie A; Rich, Jamie R; Lallous, Nada; Fazli, Ladan; Lee, Sherry S; Douglas, James; Todenhöfer, Tilman; Esfandnia, Shaghayegh; Battsogt, Dulguun; Babcook, John S; ... (2017). An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer. European urology, 72(1), pp. 142-150. Elsevier 10.1016/j.eururo.2017.03.021
Kiss, Bernhard; Wyatt, Alexander W; Douglas, James; Skuginna, Veronika Olga; Mo, Fan; Anderson, Shawn; Rotzer, Diana; Fleischmann, Achim; Genitsch Gratwohl, Vera; Hayashi, Tetsutaro; Neuenschwander, Maja; Buerki, Christine; Davicioni, Elai; Collins, Colin; Thalmann, George; Black, Peter C; Seiler, Roland (2017). Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy. Scientific Reports, 7(42713), p. 42713. Nature Publishing Group 10.1038/srep42713
Lalonde, Emilie; Ishkanian, Adrian S; Sykes, Jenna; Fraser, Michael; Ross-Adams, Helen; Erho, Nicholas; Dunning, Mark J; Halim, Silvia; Lamb, Alastair D; Moon, Nathalie C; Zafarana, Gaetano; Warren, Anne Y; Meng, Xianyue; Thoms, John; Grzadkowski, Michal R; Berlin, Alejandro; Have, Cherry L; Ramnarine, Varune R; Yao, Cindy Q; Malloff, Chad A; ... (2014). Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study. The lancet oncology, 15(13), pp. 1521-1532. Elsevier 10.1016/S1470-2045(14)71021-6
